发明名称 |
TREATMENT OF MUSCLE DISEASE CHARACTERIZED BY INSULIN RESISTANCE |
摘要 |
It is reported herein that certain muscle diseases and conditions, including forms of muscular dystrophy, are characterized by impaired insulin-dependent signaling in the muscle tissue, in essence, a form of insulin resistance. The present disclosure relates to therapeutic agents, compositions and methods for treating a muscle disease or condition characterized by impaired insulin-dependent signaling by targeting components of the defective insulin signaling pathway. The disease or condition may be treated by administering a therapeutic agent that activates the insulin signaling pathway, in particular, therapeutic agents that act post- insulin receptor to modulate intracellular effector molecules. An exemplary modulator is metformin. Metformin may be administered alone or may be co¬ administered with another therapeutic agent for treating the muscle disease or condition, such as a corticosteroid. |
申请公布号 |
WO2010132982(A1) |
申请公布日期 |
2010.11.25 |
申请号 |
WO2010CA00734 |
申请日期 |
2010.05.18 |
申请人 |
OTTAWA HOSPITAL RESEARCH INSTITUTE;FATE THERAPEUTICS (CANADA) INC.;MEGENEY , LYNN;EVANS , CAROL;SLASSI , ABDELMALIK |
发明人 |
MEGENEY , LYNN;EVANS , CAROL;SLASSI , ABDELMALIK |
分类号 |
C07C279/26;A61K31/155;A61P21/00;C07C313/30;G01N33/74 |
主分类号 |
C07C279/26 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|